首页 › 基金 › Birchview Capital, LP › RLMD
Birchview Capital, LP 对 RLMD 的持仓历史
RELMADA THERAPEUTICS INC · 医疗保健
Birchview Capital, LP 在 Q3 2026 的 13F 申报中披露持有 RLMD(RELMADA THERAPEUTICS INC)408,100 股,市值约 US$1.5M,约占其申报组合的 0.92%,在其申报持仓中市值排名第 28 位。 Birchview Capital, LP 最近 3 个申报季度中有 3 个季度披露了 RLMD 持仓,最早可追溯至 Q1 2026。
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
Birchview Capital, LP 对 RLMD 的持仓演变
Birchview Capital, LP 于 Q1 2026 首次披露 RLMD 持仓:409,387 股(约 US$2.8M)。 在 3 次申报中,Birchview Capital, LP 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 408,100 股、市值约 US$1.5M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2026 | 409.39K | $2.85M | 新进 |
| Q2 2026 | 408.10K | $2.82M | 持有 |
| Q3 2026 | 408.10K | $1.54M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 RLMD 与 13F 数据
RLMD(RELMADA THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 70 只申报持有 RLMD,申报仓位最大的包括:Squadron Capital Management LLC (US$50.9M), Venrock Adviser, LLC (US$47.4M), Spruce Street Capital LP (US$26.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 RLMD 的基金
- Squadron Capital Management LLC 7.35M 股 · $50.86M · Q2 2026
- Venrock Adviser, LLC 6.84M 股 · $47.36M · Q2 2026
- Spruce Street Capital LP 6.91M 股 · $26.06M · Q3 2026
- Jones Hill Capital LP 5.24M 股 · $19.75M · Q3 2026
- Ikarian Capital, LLC 2.15M 股 · $14.87M · Q2 2026
- STEMPOINT CAPITAL LP 1.46M 股 · $10.10M · Q2 2026
- Commodore Capital LP 1.43M 股 · $9.86M · Q2 2026
- Sio Capital Management, LLC 1.00M 股 · $6.94M · Q2 2026
- Opaleye Management Inc. 935.00K 股 · $6.47M · Q2 2026
- Boxer Capital Management, LLC 842.11K 股 · $5.83M · Q2 2026
- GREAT POINT PARTNERS LLC 842.11K 股 · $5.83M · Q2 2026
- AdvisorShares Investments LLC 670.86K 股 · $2.53M · Q3 2026
更多关于 Birchview Capital, LP
常见问题
How long has Birchview Capital, LP held RLMD?
Birchview Capital, LP has disclosed RLMD holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Birchview Capital, LP's current position in RLMD?
As of Q3 2026, Birchview Capital, LP holds 408.10K shares of RLMD (RELMADA THERAPEUTICS INC), valued at $1.54M, representing 0.92% of its reported portfolio and ranking #28.
Has Birchview Capital, LP been buying or selling RLMD?
In the latest 13F filing (Q3 2026), Birchview Capital, LP held unchanged its position in RLMD.
Which other funds hold RLMD?
Other major institutional holders of RLMD include Squadron Capital Management LLC, Venrock Adviser, LLC, Spruce Street Capital LP, among 70 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.